Cost effectiveness of a clinical pharmacist on a neurosurgical team

Neurosurgery

Volumn 65, Issue 5, 2009, Pages 946-950

  Weant, Kyle A ^a   Armitstead, John A ^a   Ladha, Alim M ^b   Sasaki Adams, Deanna ^b   Hadar, Eldad J ^b   Ewend, Matthew G ^b  

^a University of Kentucky   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Clinical services; Cost savings; Critical care; Interventions; Neurosurgery; Pharmacy

Indexed keywords

ADULT; ARTICLE; CLINICAL PHARMACY; CLINICAL PRACTICE; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; ECONOMIC ASPECT; FEMALE; HEALTH CARE QUALITY; HOSPITAL DEPARTMENT; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; INTRAVENOUS ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROSURGERY; PATIENT MONITORING; PHARMACIST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

ADULT; COST-BENEFIT ANALYSIS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; NEUROSURGERY; PATIENT CARE TEAM; PHARMACISTS;

EID: 70350314699     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000347090.22818.35     Document Type: Article

References (28)

1. American College of Critical Care Medicine of the Society of Critical Care Medicine: Critical care services and personnel: Recommendations based on a system of categorization into two levels of care. Crit Care Med 27:422-426, 1999.
2. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998: ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. Am J Health Syst Pharm 56:347-379, 1999.
3. Averill RF, Goldfield N, Hughes JS, Bonazelli J, McCullough EC, Steinbeck BA, Mullin R, Tang AM, Muldoon J, Tuner L, Gay J: All Patient Refined Diagnosis Related Groups (APR-DRGs) Version 20.0: Methodology Overview. Wallingford, 3M Health Information Systems, 2003.
4. Bond CA, Raehl CL, Franke T: Clinical pharmacy services and hospital mortality rates. Pharmacotherapy 19:556-564, 1999.
5. Bratzler DW, Houck PM: Antimicrobial prophylaxis for surgery: An advisory statement from the National Surgical Infection Prevention Project. Am J Surg 189:395-404, 2005.
6. Brilli RJ, Spevetz A, Branson RD, Campbell GM, Cohen H, Dasta JF, Harvey MA, Kelley MA, Kelly KM, Rudis MI, St Andre AC, Stone JR, Teres D, Weled BJ: Critical care delivery in the intensive care unit: Defining clinical roles and the best practice model. Crit Care Med 29:2007-2019, 2001.
7. Burke JM, Miller WA, Spencer AP, Crank CW, Adkins L, Bertch KE, Ragucci DP, Smith WE, Valley AW: Clinical pharmacist competencies. Pharma-cotherapy 28:806-815, 2008.
8. Coleman EA, Smith JD, Raha D, Min SJ: Posthospital medication discrepancies: Prevalence and contributing factors. Arch Intern Med 165:1842-1847, 2005.
9. Crotty M, Rowett D, Spurling L, Giles LC, Phillips PA: Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother 2:257-264, 2004.
10. Dager WE, Albertson TE: Impact of therapeutic drug monitoring of intravenous theophylline regimens on serum theophylline concentrations in the medical intensive care unit. Ann Pharmacother 26:1287-1291, 1992.
11. Dasta JF, Segal R, Cunningham A: National survey of critical-care pharmaceutical services. Am J Hosp Pharm 46:2308-2312, 1989.
12. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM: Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: Results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med 159:1939-1945, 1999.
13. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG: Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 [Suppl 3]:338S-400S, 2004.
14. Ibrahim KH, Gunderson B, Rotschafer JC: Intensive care unit antimicrobial resistance and the role of the pharmacist. Crit Care Med 29 [Suppl 4]:N108-N113, 2001.
15. Kane SL, Weber RJ, Dasta JF: The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med 29:691-698, 2003.
16. Katona BG, Ayd PR, Walters JK, Caspi M, Finkelstein BW: Effect of a pharmacist's and a nurse's interventions on cost of drug therapy in a medical intensive-care unit. Am J Hosp Pharm 46:1179-1182, 1989.
17. Kaye J, Ashline V, Erickson D, Zeiler K, Gavigan D, Gannon L, Wynne P, Cooper J, Kittle W, Sharma K, Morton J: Critical care bug team: A multidisciplinary team approach to reducing ventilator-associated pneumonia. Am J Infect Control 28:197-201, 2000.
18. Lazarou J, Pomeranz BH, Corey PN: Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 279:1200-1205, 1998.
19. Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, Bates DW: Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 282:267-270, 1999.
20. Maclaren R, Devlin JW, Martin SJ, Dasta JF, Rudis MI, Bond CA: Critical care pharmacy services in United States hospitals. Ann Pharmacother 40:612-618, 2006.
21. McMullin ST, Hennenfent JA, Ritchie DJ, Huey WY, Lonergan TP, Schaiff RA, Tonn ME, Bailey TC: A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med 159:2306-2309, 1999.
22. Moffett BS, Mott AR, Nelson DP, Gurwitch KD: Medication dosing and renal insufficiency in a pediatric cardiac intensive care unit: Impact of pharmacist consultation. Pediatr Cardiol 29:744-748, 2007.
23. Murray MD, Young J, Hoke S, Tu W, Weiner M, Morrow D, Stroupe KT, Wu J, Clark D, Smith F, Gradus-Pizlo I, Weinberger M, Brater DC: Pharmacist intervention to improve medication adherence in heart failure: A randomized trial. Ann Intern Med 146:714-725, 2007.
24. Pasternak JJ, Lanier WL: Neuroanesthesiology review-2007. J Neurosurg Anesthesiol 20:78-104, 2008.
25. Pronovost P, Weast B, Schwarz M, Wyskiel RM, Prow D, Milanovich SN, Berenholtz S, Dorman T, Lipsett P: Medication reconciliation: A practical tool to reduce the risk of medication errors. J Crit Care 18:201-205, 2003.
26. Sostarich AM, Zolldann D, Haefner H, Luetticken R, Schulze-Roebecke R, Lemmen SW: Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay. Infection 36:31-35, 2008.
27. The Joint Commission. http://www.jointcommission.org. Accessed May 18, 2008.
28. Welty TE: Neurology and neurosurgery clinical pharmacy practice: Ignorance, phobia, or progress? Ann Pharmacother 40:2235-2237, 2006.